170 related articles for article (PubMed ID: 36586078)
1. PRAME Staining in Sinonasal Mucosal Melanoma: A Single-Center Experience.
Scheurleer WFJ; Braunius WW; Tijink BM; Suijkerbuijk KPM; Dierselhuis MP; Meijers RWJ; Blokx WAM; de Bree R; Breimer GE; Rijken JA
Head Neck Pathol; 2023 Jun; 17(2):401-408. PubMed ID: 36586078
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases.
Durzynska M; Dos Santos FLC; Matuszczyk A; Derezinska-Wolek E; Michalek IM
Anticancer Res; 2023 Oct; 43(10):4551-4557. PubMed ID: 37772580
[TBL] [Abstract][Full Text] [Related]
3. PRAME expression in 137 primary cutaneous melanomas and comparison with 38 related metastases.
Lo Bello G; Pini GM; Giagnacovo M; Patriarca C
Pathol Res Pract; 2023 Nov; 251():154915. PubMed ID: 37913637
[TBL] [Abstract][Full Text] [Related]
4. Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas.
Toyama A; Siegel L; Nelson AC; Najmuddin M; Bu L; LaRue R; Henzler C; Caicedo-Granados E; Giubellino A; Li F
Mod Pathol; 2019 Dec; 32(12):1727-1733. PubMed ID: 31375769
[TBL] [Abstract][Full Text] [Related]
5. PRAME Expression in Mucosal Melanoma of the Head and Neck Region.
Ricci C; Altavilla MV; Corti B; Pasquini E; Presutti L; Baietti AM; Amorosa L; Balbi T; Baldovini C; Ambrosi F; Grillini M; D'Errico A; Fiorentino M; Foschini MP
Am J Surg Pathol; 2023 May; 47(5):599-610. PubMed ID: 36912431
[TBL] [Abstract][Full Text] [Related]
6. PRAME immunohistochemistry is useful in the diagnosis of oral malignant melanoma.
Hovander D; Allen J; Oda D; Moshiri AS
Oral Oncol; 2022 Jan; 124():105500. PubMed ID: 34452831
[TBL] [Abstract][Full Text] [Related]
7. Sinonasal melanoma. A clinicopathologic study of 25 cases and literature meta-analysis.
Brandwein MS; Rothstein A; Lawson W; Bodian C; Urken ML
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):290-6. PubMed ID: 9076235
[TBL] [Abstract][Full Text] [Related]
8. PRAME expression in 155 cases of metastatic melanoma.
Gradecki SE; Slingluff CL; Gru AA
J Cutan Pathol; 2021 Apr; 48(4):479-485. PubMed ID: 32939793
[TBL] [Abstract][Full Text] [Related]
9. Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.
Samstein RM; Carvajal RD; Postow MA; Callahan MK; Shoushtari AN; Patel SG; Lee NY; Barker CA
Head Neck; 2016 Sep; 38(9):1310-7. PubMed ID: 27043023
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a series of 85 cases.
Broggi G; Failla M; Russo A; Longo A; Palicelli A; Zanelli M; Lombardo C; Loreto C; Merolla F; Di Crescenzo RM; Ilardi G; Varricchio S; Staibano S; Caltabiano R
Pathol Res Pract; 2023 Jul; 247():154543. PubMed ID: 37210771
[TBL] [Abstract][Full Text] [Related]
11. Analysis of PRAME immunocytochemistry in 109 acral malignant melanoma in situ.
Miao QJ; Zang J; Shao XB; Sun JF; Chen YP; Chen H
J Clin Pathol; 2024 May; 77(6):417-420. PubMed ID: 36882315
[TBL] [Abstract][Full Text] [Related]
12. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
Lohman ME; Steen AJ; Grekin RC; North JP
J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
Lezcano C; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
[TBL] [Abstract][Full Text] [Related]
14. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
Bahmad HF; Oh KS; Alexis J
J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
[TBL] [Abstract][Full Text] [Related]
15. PRAME expression in cutaneous melanoma does not correlate with disease-specific survival.
Parra O; Ma W; Li Z; Coffing BN; Linos K; LeBlanc RE; Momtahen S; Sriharan A; Cloutier JM; Wells WA; Yan S
J Cutan Pathol; 2023 Oct; 50(10):903-912. PubMed ID: 37430414
[TBL] [Abstract][Full Text] [Related]
16. PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer.
Cassalia F; Danese A; Tudurachi I; Federico S; Zambello A; Guidotti A; Franceschin L; Bolzon A; Naldi L; Belloni Fortina A
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338862
[TBL] [Abstract][Full Text] [Related]
17. PRAME Expression in Melanocytic Tumors.
Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
[TBL] [Abstract][Full Text] [Related]
18. Intragenic NF1 deletions in sinonasal mucosal malignant melanoma.
Riobello C; Casanueva Muruais R; Suárez-Fernández L; García-Marín R; Cabal VN; Blanco-Lorenzo V; Franchi A; Laco J; López F; Llorente JL; Hermsen MA
Pigment Cell Melanoma Res; 2022 Jan; 35(1):88-96. PubMed ID: 34547192
[TBL] [Abstract][Full Text] [Related]
19. PRAME Expression Is a Useful Tool in the Diagnosis of Primary and Metastatic Dedifferentiated and Undifferentiated Melanoma.
Hornick JL; Plaza JA; Mentzel T; Gru AA; Brenn T
Am J Surg Pathol; 2023 Dec; 47(12):1390-1397. PubMed ID: 37727938
[TBL] [Abstract][Full Text] [Related]
20. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
